Thus, peretinoin enhanced autophagy by increasing Atg5-Atg12-Atg16L1 pathway activation and reduced steatosis, inflammation, and tumorigenesis in 2 different NASH-HCC mouse models. Here, ATG16L1 is linked to metabolic dysfunction-associated steatohepatitis.